blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2736908

EP2736908 - BICYCLIC PYRIMIDONE COMPOUNDS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.10.2016
Database last updated on 20.07.2024
Most recent event   Tooltip21.10.2016Application deemed to be withdrawnpublished on 23.11.2016  [2016/47]
Applicant(s)For all designated states
Glaxo Group Limited
980 Great West Road
Brentford
Middlesex TW8 9GS / GB
[2014/23]
Inventor(s)01 / WAN, Zehong
GlaxoSmithKline (China) R&D Co. Ltd.
Building 3
898 Halei Road
Zhangjiang Hi-Tech Park
Shanghai 201203 / CN
02 / LONG, Kai
GlaxoSmithKline (China) R&D Co. Ltd.
Building 3
898 Halei Road
Zhangjiang Hi-Tech Park
Shanghai 201203 / CN
03 / ZHANG, Xiaomin
GlaxoSmithKline (China) R&D Co. Ltd.
Building 3
898 Halei Road
Zhangjiang Hi-Tech Park
Shanghai 201203 / CN
04 / YU, Haihua
GlaxoSmithKline (China) R&D Co. Ltd.
Building 3
898 Halei Road
Zhangjiang Hi-Tech Park
Shanghai 201203 / CN
 [2014/23]
Representative(s)Jewson, Rie
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2014/23]
Application number, filing date12738465.925.07.2012
WO2012EP64598
Priority number, dateWO2011CN7770227.07.2011         Original published format: PCT/CN2011/077702
[2014/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013014185
Date:31.01.2013
Language:EN
[2013/05]
Type: A1 Application with search report 
No.:EP2736908
Date:04.06.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 31.01.2013 takes the place of the publication of the European patent application.
[2014/23]
Search report(s)International search report - published on:EP31.01.2013
ClassificationIPC:C07D487/04, A61K31/519, A61P25/28
[2014/23]
CPC:
C07D487/04 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
A61P3/06 (EP); A61P9/10 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/23]
Extension statesBA04.02.2014
ME04.02.2014
TitleGerman:BICYCLISCHE PYRIMIDONVERBINDUNGEN[2014/23]
English:BICYCLIC PYRIMIDONE COMPOUNDS[2014/23]
French:COMPOSÉS PYRIMIDONES BICYCLIQUES[2014/23]
Entry into regional phase04.02.2014National basic fee paid 
04.02.2014Designation fee(s) paid 
04.02.2014Examination fee paid 
Examination proceduredeletedCommunication of intention to grant the patent
04.02.2014Amendment by applicant (claims and/or description)
04.02.2014Examination requested  [2014/23]
02.02.2016Despatch of a communication from the examining division (Time limit: M04)
14.06.2016Application deemed to be withdrawn, date of legal effect  [2016/47]
11.07.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/47]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.02.2016
Fees paidRenewal fee
08.07.2014Renewal fee patent year 03
09.07.2015Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.07.201605   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO03087088  (GLAXO GROUP LTD [GB], et al) [AD] 1-19 * See the examples *;
 [AD]WO2008048867  (GLAXO GROUP LTD [US], et al) [AD] 1-19 * claim 1 *
by applicantWO9613484
 WO9619451
 WO9702242
 WO9712963
 WO9721675
 WO9721676
 WO9741098
 WO9741099
 WO9924420
 WO0010980
 WO0066566
 WO0066567
 WO0068208
 WO0160805
 WO0230904
 WO0230911
 WO03015786
 WO03016287
 WO03041712
 WO03042179
 WO03042206
 WO03042218
 WO03086400
 WO03087088
 WO2008048867
 US2008103156
 US2008090851
 US2008090852
 WO2008048866
 WO2005003118
 CA2530816
 WO2006063811
 WO2006063813
 WO2008141176
 JP2001088847
 US2008279846
 US2010239565
 US2008280829
 WO9702037
 WO9828310
 WO9828311
 WO9828312
    - ZALEWSKI A ET AL., ARTERIOSCLER. THROMB. VASC. BIOL., (2005), vol. 25, no. 5, pages 923 - 31
    - WILENSKY ET AL., CURRENT OPINION IN LIPIDOLOGY, (2009), vol. 20, pages 415 - 420
    - WILENSKY ET AL., NATURE MEDICINE, (2008), vol. 10, pages 1015 - 1016
    - VAN OIJEN ET AL., ANNALS OF NEUROLOGY, (2006), vol. 59, page 139
    - KASSNER ET AL., CURRENT ALZHEIMER RESEARCH, (2008), vol. 5, pages 358 - 366
    - DILDAR ET AL., ALZHEIMER DIS ASSOC DISORD, (201004), vol. 24
    - SINEM ET AL., CURRENT ALZHEIMER RESEARCH, (2010), vol. 7, pages 463 - 469
    - COLANGELO ET AL., JOURNAL OF NEUROSCIENCE RESEARCH, (2002), vol. 70, pages 462 - 473
    - WYSS-CORAY, NATURE MEDICINE, (200609), vol. 12
    - SHI ET AL., ATHEROSCLEROSIS, (2007), vol. 191, pages 54 - 62
    - PERRY, ACTA NEUROPATHOL, (2010), vol. 120, pages 277 - 286
    - BUSCHINI ET AL., PROGRESS IN NEUROBIOLOGY, (2011), vol. 95, pages 14 - 25
    - TEZEL, Progress in Brain Research, vol. 173
    - BERGE ET AL., J. PHARM, SCI., (1977), vol. 66, pages 1 - 19
    - P L GOULD, INTERNATIONAL JOURNAL OF PHARMACEUTICS, (1986), vol. 33, pages 201 - 217
    - BIGHLEY ET AL., Encyclopedia of Pharmaceutical Technology, MARCEL DEKKER INC, (1996), vol. 13, pages 453 - 497
    - MARTINEZ FO ET AL., J IMMUNOL, (2006), vol. 177, pages 7303 - 7311
    - LAMB J ET AL., SCIENCE, (2006), vol. 313, pages 1929 - 1935
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY
    - The Handbook of Pharmaceutical Additives, GOWER PUBLISHING LIMITED
    - The Handbook of Pharmaceutical Excipients, AMERICAN PHARMACEUTICAL ASSOCIATION AND THE PHARMACEUTICAL PRESS
 WO2011CN01597
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.